Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia

被引：4
|
作者：
Vargas, RL [1 ]
Felgar, RE [1 ]
Rothberg, PG [1 ]
机构：
[1] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2005年 / 97卷 / 14期
关键词：
D O I：
10.1093/jnci/dji119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1089 / 1090
页数：2
相关论文
共 50 条
  • [41] Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia
    M H A van Attekum
    S Terpstra
    E Slinger
    M von Lindern
    P D Moerland
    A Jongejan
    A P Kater
    E Eldering
    Oncogene, 2017, 36 : 3651 - 3660
  • [42] The Prognostic Significance of Autoinumme Cytopenias in Patients with Chronic Lymphocytic Leukemia
    Moreno, Carol
    Hodgson, Kate E.
    Abrisqueta, Pau
    Ferrer, Gerardo
    Elena, Montse
    Pereira, Arturo
    Bosch, Francesc
    Montserrat, Emili
    BLOOD, 2009, 114 (22) : 932 - 932
  • [43] Prognostic significance of circulating angiogenic cytokines in chronic lymphocytic leukemia
    Smolej, Lukas
    Andrys, Ctirad
    Vodarek, Pavel
    Motyckova, Monika
    Simkovic, Martin
    Belada, David
    Zak, Pavel
    LEUKEMIA & LYMPHOMA, 2020, 61 : 210 - 211
  • [44] Prognostic significance of serum immunoglobulin pareprotein in chronic lymphocytic leukemia
    杨舒
    ChinaMedicalAbstracts(InternalMedicine), 2012, 29 (04) : 233 - 234
  • [45] Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia
    Veronese, Lauren
    Tournilhac, Olivier
    Verrelle, Pierre
    Davi, Frederic
    Dighiero, Guillaume
    Chautard, Emmanuel
    Veyrat-Masson, Richard
    Kwiatkowski, Fabrice
    Goumy, Carole
    Gouas, Laetitia
    Bay, Jacques-Olivier
    Vago, Philippe
    Tchirkov, Andrei
    LEUKEMIA RESEARCH, 2009, 33 (12) : 1623 - 1626
  • [46] The Impact and Prognostic Significance of Chronic Lymphocytic Leukemia Upregulated 1 (CLLU1) Gene Expression in Patients with Chronic Lymphocytic Leukemia: A Single Center Experience
    Sevinc, Mustafa
    Karabulut, Aydin
    Eskazan, Ahmet Emre
    Tatonyan, Suzin Catal
    Ozbek, Ugur
    Soysal, Teoman
    LABORATORY MEDICINE, 2020, 51 (03) : 259 - 264
  • [47] Methylation of the ABL1 promoter in chronic myelogenous leukemia:: Lack of prognostic significance
    Issa, JPJ
    Kantarjian, H
    Mohan, A
    O'Brien, S
    Cortes, J
    Pierce, S
    Talpaz, M
    BLOOD, 1999, 93 (06) : 2075 - 2080
  • [48] Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity
    Smit, Laura A.
    Hallaert, Delfine Y. H.
    Spijker, Ren
    de Goeij, Bart
    Jaspers, Annelieke
    Kater, Arnon P.
    van Oers, Marinus H. J.
    van Wesel, Carel J. M.
    Eldering, Eric
    BLOOD, 2007, 109 (04) : 1660 - 1668
  • [49] SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia
    Paiva, Cody
    Rowland, Taylor A.
    Sreekantham, Bhargava
    Godbersen, Claire
    Best, Scott R.
    Kaur, Prabhjot
    Loriaux, Marc M.
    Spurgeon, Stephen E. F.
    Danilova, Olga V.
    Danilov, Alexey V.
    HAEMATOLOGICA, 2017, 102 (11) : 1890 - 1900
  • [50] Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab
    Awan, Farrukh T.
    Kay, Neil E.
    Davis, Melanie E.
    Wu, Wenting
    Geyer, Susan M.
    Leung, Nelson
    Jelinek, Diane F.
    Tschumper, Renee C.
    Secreto, Charla R.
    Lin, Thomas S.
    Grever, Michael R.
    Shanafelt, Tait D.
    Zent, Clive S.
    Call, Timothy G.
    Heerema, Nyla A.
    Lozanski, Gerard
    Byrd, John C.
    Lucas, David M.
    BLOOD, 2009, 113 (03) : 535 - 537
12345